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 Candida albicans is a dormant commensal in the mucosa of healthy individuals 
but can become an opportunistic pathogen when the host microflora is compromised. It 
has been reported as the most common cause of fungal infection among hospitalized 
U.S. patients, with elevated mortality rate. Candida species have been reported as 
resistant to antifungal drugs that increase the application of novel strategies to treat this 
infection. Among the natural compounds that have most gained attention as potential 
agents against fungi are phenolic compounds against fungi. C. albicans has the ability to 
switch phenotype from yeast-to-hyphae cells, with hyphae being the most invasive form; 
therefore, therapies aiming to impair this morphologic transition can be promising 
against this fungus. The main objective of this work was to evaluate the ability of isolated 
phenolics to prevent the yeast-to-hyphae transition of C. albicans by modulating the 
activity of the enzyme complexes involved in oxidative phosphorylation. Also, C. albicans 
strains (SC5314 and A72) responded significantly differently to the OXPHOS respiration 
even though they showed similar morphologies. Cells were treated with certain 
concentrations of gallic and ferulic acid in isolation determined to prevent hyphal growth 
by 25-50%. Results showed that gallic and ferulic acids inhibited the enzyme activity 
involved in oxidative phosphorylation of C. albicans (SC5314 and A72).   
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1. LITERATURE REVIEW 
1. A.    Candida albicans Morphology and Pathogenicity:  
Candida albicans inhabits the gastrointestinal tract as a typical commensal 
member of the microbiota but can become an opportunistic pathogen when the host 
microflora is compromised. Candida infections (candidiasis) can be life-threatening, 
particularly in individuals who are critically ill; (e.g., those with immunodeficiency 
syndrome, or hematological malignancy), causing mortality rates of over 30-40% 
(Morgan et al. 2005). The Centers for Disease Control has estimated that 46,000 cases 
of invasive candidiasis occur every year in the US (Centers for Disease Control and 
Prevention and US Department of Health and Human Services, 2013).  
The most common form of invasive candidiasis is candidemia, which is now the 
most frequent bloodstream infection in the US (Magill et al. 2014). Candida species are 
the fourth main cause of hematogenous infections, such as candidiasis, in individuals 
with compromised immune systems (Horn et al. 2009; Wisplinghoff et al. 2004). 
Candidiasis has also been loosely associated with other non-emergent albeit debilitating 
conditions, such as denture stomatitis, allergic reactions, depression, diabetes and more 
recently obesity (Guggenheimer et al. 2000; Edward 1985; Srebrnik 1990; Salerno et al. 
2011). 
C. albicans is able to evade the immune system defenses of the host in order to 
survive due to its ability to switch phenotypes (Sudbury et al. 2004). Transcription of 
hyphal-specific genes is initiated by a network of environmental sensing and signaling 
transduction pathways (Biswas et al. 2007). Therefore, when C. albicans yeast is 
challenged by certain environmental cues, the hyphae switch is triggered (Schulze 
2009).  From the tip, a single germ tube evaginates and elongates. Candida then 
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synthesizes and maintains a continuous supply of materials as well as enzymes for 
elongating the new cell wall (Tournu 2011).  Interestingly, C. albicans can even elongate 
without mitochondrial function when a fermentable carbon source is available, such as 
glucose (Gyurko et al. 2000; Geraghty and Kavanagh 2003). The hyphal form can 
survive in conditions of natural pH, temperatures above 37 ◦C, low O2, serum and high 
CO2 levels (Howard et al. 2007). This unique yeast can also survive under conditions of 
oxidative stress, which can regulate the expression of individual complexes present in 
the electron transfer chain and thereby control electron flow between the enzymes 
proton production and ultimately energy levels (Cavalheiro et al. 2004). Moreover, in the 
event that immune phagocytes are triggered by the presence of C. albicans yeast, either 
in the bloodstream or inoculating internal organs, C. albicans switches to the hyphae 
form during the early engulfing stage. As nutrients are limited in phagocytes, C. albicans 
hyphae are able to slow down glycolysis, switch to oxidative stress response and then 
resume rapid glycolytic growth upon escape (Lorenz et al. 2004) as the phagocytes 
break down.   
Although both the yeast and hyphal form have been reported to infect internal 
organs (Felk et al. 2002), the hyphae are more adhesive than other C. albicans cells and 
more invasive (Jacobsen et al., 2012). When the bloodstream is infected by C. albicans, 
the yeast form is the typical phenotype present (Jacobsen et al., 2012). However, Dalle 
et al. (2010) showed via in vitro studies that the hyphae specifically invade both 
reconstituted epithelial and endothelial cells and cause damage. The study provides 
valuable information because C. albicans has to penetrate the mucosal barrier and 
endothelial cells to establish candidaemia and infect internal organs. There are two 
mechanisms C. albicans uses to invade epithelial cells:  induced endocytosis by cell 
invasin Als3, which bind to host E-cadherin, and active penetration (Dalle et al. 2010;  
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Figure 1.  Virulent responses of C. albicans.  
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Phan et al. 2007).  Indeed, active penetration is also responsible for an invasion of 
enterocytes (Dalle et al. 2010). (Figure 1. illustrates the different morphology and 
pathogenicity of C. albicans, some of which have not been discussed here as it beyond 
the scope of this project).  
However, C. albicans yeast is able to thrive in the form of gastrointestinal 
induced transition (GUT) cells within a healthy host without imminent damage. Indeed, 
the phenotype of GUT cells maintains the fungus in a harmless state in which virulence-
associated genes are downregulated (Pande et al. 3013). Considering that C. albicans 
benign yeast has the ability to adjust to a variety of available nutrients, virulent infections 
are dependent on the strength of the natural immune system (Brown et al., 2014).  Oral 
candidiasis is the most common fungal infection of the oral mucosa, as it is usually 
associated with disequilibrium of the oral microbiota by prolonged use of broad-spectrum 
antibiotics (Soysa et al., 2008) and an immunocompromised defense system (Farah et 
al.; 2010). For example, oral candidiasis occurs in up to 90% of HIV patients before the 
introduction of active antiretroviral therapy (Thompson et al., 2010). This infection can be 
classified as pseudomembranous (also known as thrush), acute erythematous, denture-
associated erythematous or chronic hyperplastic candidiasis, based on location, depth of 
epithelial invasion and host response [reviewed in Hebecker et al., (2014)]. Later stages 
of oral infection are characterized by destruction and loss of the superficial oral 
epithelium due to the invasion of long C. albicans hyphae cells (Farah et al., 2000), 
which appear to play a critical role in oral Candida infections because of their ability to 
penetrate the epithelial layer. Also, cells that are not able to switch morphology have 
been associated with the reduced capacity to invade epithelial cells in vitro and usually 
present reduced virulence in animal models of mucosal candidiasis (Park et al., 2005). 
Therefore, strategies that specifically target this virulence factor by inhibiting the yeast-
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to-hyphae transition [reviewed in Jacobsen et al. (2012)] could be used to alleviate 
clinical symptoms of oral candidiasis and other types of C. albicans infections.   
The majority of antifungal drugs commonly used today can be toxic to other cells, 
primarily eukaryotes,  due to the similarity in host and fungal cells of mechanisms 
involving DNA, RNA and protein synthesis (Shoham and Levitz, 2005), which is one of 
the main difficulties in treating fungal infections. Also, the limited diversity of the available 
antifungal drugs used to treat these infections have caused the emergence of resistant 
organisms (Pfaller et al., 2008; Smith and Andes, 2008; Spanakis et al., 2006; Holmes et 
al., 2008). Only a few classes of agents are currently on the market to treat mucosal or 
systemic Candida infections (Matthew and Nath, 2009; Kathiravan, 2012; Denning and 
Hope, 2010). These main drug families consist of Azoles (e.g., fluconazole), polyenes 
(e.g., amphotericin B), echinocandins (e.g., caspofungin) and nucleoside analogues 
(e.g., flucytosine) with the first two cited drugs being the most commonly used (Denning 
and Hope, 2010; Dodds et al., 2010; Bekersky et al. 2002; Alves et al., 2014; Heimark et 
al., 2002). Azole-resistant C. albicans is frequent in HIV-infected patients with 
oropharyngeal candidiasis (Skiest et al., 2007; Sanglard and Odds, 2002), while minimal 
resistance to the polyene amphotericin B has been reported, although side effects and 
toxicity caused by this class are well-known (Laniado-Laborín and Cabrales-Vargas, 
2002; Ellis, 2002). The major mechanisms leading to antifungal drug resistance in 
Candida is provided in an excellent review by Spampinato and Leonardi (2013).  It must 
be emphasized that treatment with conventional antifungals can also eliminate 
microbiota members that are Candida’s natural competitors, which in turn can increase 
the severity of the infection (Candiracci et al. 2011; Kathiravan et al. 2012; Denning and 
Hope 2010).   
The yeast to hyphae morphology can be induced in the laboratory depending on 
the growth medium and incubation conditions (Biwas et al., 2007; Veses and Gow, 
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2009) allowing for controlled experiments to develop novel anti-fungal agents that target 
the phenotypic switch.  Moreover, due to the relationship of pathogenicity of C. albicans 
to its ability to switch from unicellular budding yeasts to a hyphae phenotype (Gow, 
2013), this phenotypic switch presents a unique target for preventing or remediating the 
virulent state by compounds, such as natural products, without killing a commensal 
organism of our microbiome.     
1. B. Anti-hyphal Properties of Phenols  
Considering the emergence of C. albicans strains resistant to commonly used 
antifungal agents, the development of innovative and multiple targeted anti-fungal 
agents is critically needed. Phenolic compounds present in plant systems have shown 
such promise due to their ability to complex proteins, disrupt microbial membranes, or 
act as cell signaling agents (Papadopoulou et al. 2005; Kanwala et al. 2010; Candiracci 
et al. 2012; Bravo and Lazo 1996; Hirasawa and Takada 2004). The compounds, 
phenols, are uniquely positioned to fill this need because as secondary metabolites in 
plants, it is their function to protect their host against multiple stress conditions, including 
microbial invasions and abiotic (e.g., UV light) stresses (Tomás et al. 2000; Treutter, 
2005).   
Over 8000 polyphenolic structures have been identified (Baxter et al. 1998), and 
these are categorized by the presence of one or more aromatic rings bonded to one or 
more hydroxyl groups (Ignat et al. 2011). Phenols are further divided into several 
additional groups, such as flavonoids, phenolic acids, tannins, and lignans, based on 
their chemical structures (D’Archivio et al. 2007) (Figure 2), and then separated by the 
position of hydroxyl groups or acid groups (such as in the case of phenolic acids) (Figure 
3 and 4). Also, the basic structure of each of these compounds can be derivatized to 
different positions on the main structure by various compounds, but typically sugar 
groups serve this purpose (Bravo 1998). Despite their different structures, many of these  
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Figure 2: Categories of phenols based on structures.   
 
 
 
 
 
 
8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Structure of different types of phenolic acids classified as hydroxycinnamic 
acids due to the conjugated bond between the phenols and the acid groups. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4:  Structure of different types of phenolic acids classified as              
hydroxybenzoic acids due to the covalent bond between the phenol and the acid 
group.  
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phenolic components share ordinary bioactive activities, albeit to varying degrees, which 
include the ability to scavenge free radicals and to modulate specific cellular enzyme 
activities (Cai et al., 2006; Chen and Blumberg, 2008; Masella et al. , 2005). As such, 
they have been shown to protect the human body against several chronic diseases, 
such as cancer, heart disease, Alzheimer's disease, and obesity (Hertog et al., 1993; 
Huang and Ferraro, 1992; Teixeira et al., 2013). Phenolic compounds are also able to 
enhance the healthy state of diseased cells by acting upon multiple carbohydrate 
metabolic pathways (Arathi and Sachdanandam, 2003; Kueck et al., 2007; Suolinna et 
al., 1975), including within the mitochondria.  For example, Jagatha et al. (2008) 
determined that curcumin protected mitochondrial complex I activity from stress in 
dopaminergic neuronal cells. In addition, epigallocatechin gallate was able to increase 
enzyme activity of select tricarboxylic acid (TCA) cycle proteins and thus protect electron 
transfer complexes’ function from mitochondrial oxidative damage in rat models 
(Srividhya et al. 2009). 
Indeed, the antifungal activity of phenolic compounds against several fungal 
genera is well documented in the following review (Guzman 2014).  As an example, 
epicatechin and quercetin isolated from the leaves of mango showed an increase of 
antifungal activity with an increase in their concentration against five different fungal 
species (Kanwal et al. 2010). Yet, the phenolic protection against yeast has primarily 
been studied based on the ability of phenolics to inhibit cellular growth (Gallucci et al. 
2014; Faria et al. 2011; Candiacci et al. 2011; Guzman 2014; Kanwal et al. 2010).  As an 
example, gallic acid extracted from hydrolyzable tannin was able to kill or inhibit the 
growth of C. albicans cells (Hong et al. 2011), but its effect on virulence factors was not 
determined. Gallic acid and quercetin identified from flowers of North Eastern Portugal 
showed antifungal activity against all Candida species biofilms (Alves el al. 2014). Also, 
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ferulic acid provided antimicrobial protection by inhibiting the growth of Candida species 
(Ergün et al. 2011).   
Nonetheless, other, albeit limited, studies have targeted the virulence factors of 
C. albicans. Phenol-rich curcumin was able to inhibit reactive oxygen species produced 
by the Candida albicans hyphal phenotype, and thereby mitigate damage to engulfing 
phagocytes or epithelial layers for penetration into the bloodstream (Sharma et al. 2010).  
Kazuko et al. (2010) demonstrated that yeast-to-hyphae transition and the extent of 
hyphal growth was inhibited by resveratrol. Saito et al. (2013) showed the ability of the 
flavonoid, catechin, to inhibit the transition to  C. albicans hyphal phenotype. The 
phenolic acid, gallic acid, has also been reported to prevent the in vitro formation of C. 
albicans biofilms (Wang et al. 2009).  Also, benzyl was able to reduce hyphae formation 
and affect biofilm formation of C. albicans (Zhang et al. 2011).   
Although phenolic compounds are consumed daily, they suffer from low 
bioavailability (5%) and spend little time in the body (< 24 h), which predicates the 
hypothesis that this diverse group of agents most likely are working together to provide a 
health benefit. For example, phenol-rich extracts obtained from honey and grapefruit 
were able to inhibit the hyphal transition in a dose-dependent matter that resulted in 
much lower inhibitory concentrations compared to the phenols in isolation (Candiracci et 
al. 2012; Cvetnic and Vladimir 2004). However, these studies remain limited and are 
beyond the scope of the current study, but warranted mention for future studies.   
1. C.  Respiratory chain and oxidative phosphorylation 
Energy conversion by Candida species is the fourth main cause of 
hematogenous infections in individuals with compromised immune systems (Horn et al. 
2009). This mechanism is achieved via functional mitochondria by two interconnected 
pathways that include the tricarboxylic acid (TCA) cycle and the electron transport chain 
/ oxidative phosphorylation system, both of which occur in the mitochondria, or “the 
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power house” of the cell. The TCA cycle directly or indirectly supplies carbon, via 
carbohydrate, protein or lipids (Figure 5), which are then oxidized in the inner membrane 
of the mitochondria to produce reduced nicotinamide adenine dinucleotide (NADH), 
flavin adenine dinucleotide (FADH2) and adenine trinucleotide (ATP)  (Dröse and Brandt 
2012).   
However, the majority of energy in the form of ATP would not be possible without 
the four enzyme complexes forming the produced by the electron transport system 
(ETS) and another that catalyzes AMP to ATP, i.e., the oxidative phosphorylation 
(OXPHOS) enzyme, thus the most potent respiratory chain consists of five enzyme 
complexes. Electrons are transported by these enzymes, which are embedded in the 
inner mitochondrial membrane (Mandalari et al. 2010; Strauss et al. 2008) (Figure 6). 
The electrons from NADH and FADH2 produced in the TCA are transferred to the 
electron transport chain at complexes I and II, respectively (Figure 6). This step 
regenerates NAD+ and FAD (the oxidized carriers) for use in the TCA pathway (Siedow 
and Umbach 1995). The electrons flow through the electron transport chain, causing 
protons to be pumped from the matrix to the intermembrane space. Eventually, the 
electrons are passed to oxygen, which combines with protons to form water (Moore et al. 
1995). The proton gradient generated by proton pumping during the electron transport is 
a stored form of energy. When protons flow back down the concentration gradient (from 
the intermembrane space to the matrix), their only route is through ATP synthase, 
another enzyme embedded in the inner mitochondrial membrane (Figure 6). When 
protons flow through ATP synthase, water turns a water wheel and this motion catalyzes 
the conversion of ADP and Pi to ATP (Figure 6) (Nicholls and Ferguson 2002).  
Complex I ubiquinone oxidoreductase oxidizes NADH to NAD+, passing the 
electrons to ubiquinone to form ubiquinol (Sarasota 1999; Pester and Minter 2016). 
Complex I has a unique particle L-shaped structure with two-dimensional arrays  
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Figure 5:  Sites of carbon entry by different compounds into the mitochondria via the TCA 
cycle. 
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Figure 6:  Electron transport chains, electron flow, and gradient pump and ATP synthase. 
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(Rich 2003). Complex II uses ubiquinone to oxidize succinate to fumarate. The reduction 
of ubiquinone to ubiquinol facilitates succinate oxidation resulting in additional electrons. 
Electrons are transported from Complex I or II as ubiquinone to complex III (Sun et al. 
2005). Cytochrome bc1, or Complex III, then delivers electrons from oxidized ubiquinol 
to reduced cytochrome c. The Q-cycle is responsible for proton and electron transfer via 
two pathways, starting when ubiquinone attaches to Complex III upon binding two 
electrons that flow from the two different pathways. 
One electron moves to the iron–sulphur cluster and then transfers to the heme of 
cytochrome c1 and the substrate cytochrome c. Another electron moves into the heme 
group of cytochrome b before being picked up by ubiquinone and this, in turn, reduces 
ubiquinone to ubiquinol. Cytochrome c oxidase or Complex IV is the enzyme responsible 
for transferring electrons from cytochrome c to molecular oxygen to deliver two electrons 
from reduced cytochrome c to further transfer to CuA and the heme a iron, followed by 
the heme a3 iron and lastly to CuB. A peroxide bridge then forms between the reduced 
form of CuB and heme a3. The proton breaks down the bridge and forms molecular 
water (Arnold 2012). Lastly, F1FoATPase or Complex V is responsible for the synthesis 
of ATP by using the proton motive force. The energy transfers between Fo membrane 
sectors to the F1 catalytic sector. F1 contains β (and α) subunits that each are composed 
of three-domain structures, which form the hexamer that catalyzes the synthesis of ATP 
(Saraste 1999; Belogrudov et al. 1995).  
As mentioned previously, different types of phenols can positively impact a 
stressed cell; this includes acting upon multiple carbohydrate metabolic pathways, 
including oxidative phosphorylation (Arathi and Sachdanandam 2003). As an example, 
quercetin was able to protect against mitochondrial oxidative stress in isoproterenol-
induced myocardial infarcted rats.  More specifically, this study showed that by 
consuming (10 mg/kg body weight of) quercetin daily for a period of 7 days, the treated 
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rats presented with significantly decreased activity levels of enzymes involved in 
regulating the tricarboxylic acid cycle (TCA) and respiratory chain enzymes, which were 
comparable to the negative control group (Prince and Sathya, 2012). Makovec and 
Šindelář (1984) also determined that phenolic compounds affected the activity of 
respiratory chain enzymes of potato tuber mitochondria. This study shows that several 
types of phenolics were able to inhibit respiration and phosphorylation. Indeed, succinate 
dehydrogenase activity (complex II) was the most inhibited enzyme among the 
respiratory chain enzymes, with quercetin being the most effective inhibitory phenol.  Xie 
and Chen (1999) determined that salicylic acid (SA) encourages rapid inhibition of ATP 
synthesis and respiratory O2 uptake on mitochondrial electron transport and oxidative 
phosphorylation in tobacco cells. Because mitochondria play significant roles in plant 
diseases, the effect of the SA on electron transport was a higher chance in SA-mediated 
biological processes in mitochondria function. 
Still, the effects on the activities of the respiratory proteins present during the C. 
albicans transition state have not been reported to our knowledge, yet alone when 
treated with phenols. Nevertheless, it is expected that this pathway is affected during the 
yeast-to-hyphae transition as reactive oxygen species (ROS) levels have been shown to 
change during this process.  In a study conducted by Candiracci et al. (2012) the results 
showed that flavonoids extracted from honey were able to inhibit the yeast-to-hyphae 
transition of C. albicans. This response was attributed to the suppression both ROS 
generation and γ-glutamyl transpeptidase activity, which is responsible for GSH 
degradation during hypha elongation.  Schröter et al. (2000) also reported that the levels 
of ROS production differ with C. albicans phenotypic transitions and is linked to its 
pathogenicity. More specifically, the highest ROS levels occurred during hyphae 
formation when compared to blastoconidia at the same protein level. Moreover, the 
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researchers proposed that the increased ROS levels were a consequence of disrupted 
complex I (CI) (Li et al. 2011). 
2.  OBJECTIVE AND SPECIFIC AIMS  
  The objective of this project was to determine the ability of the phenolic acids, 
ferulic and gallic, to modulate the activity of the enzyme complexes involved in oxidative 
phosphorylation as a means to maintain the benign yeast state.  This research is linked 
to oxidative phosphorylation as changes in this highly interconnected energy pathway 
are expected in such a crucial event as a phenotypic switch. The activity of the individual 
complexes II, III, IV, V, the mitochondrial matrix marker enzyme citrate synthase, and the 
combined activity of complexes II and III will be monitored at each of the following time 
points: 0, 1, 3, and 6 hours of C.albican yeast –to hyphal transition . The cited times 
were selected because previous studies completed in our laboratory have shown that C. 
albicans is biochemically active at these time points even if the morphology appears 
similar.  
Specific Aim 1:  To determine the effects on the activities of the oxidative 
phosphorylation enzymes for two strains of yeast C. albicans (SC5314 and A72) 
during their transition from yeast to hyphae phenotype. Specific Aim I is needed as 
a means to understand the relationship of oxidative phosphorylation to the virulent 
phenotypic switch for two different strains, and thus if significant changes occur between 
both. This specific aim will be accomplished by first establishing each of 5 tests 
(Complex II, II + III, IV, and V), albeit citrate synthase will be used in the final calculations 
of each.  The effects will then be compared using yeast exposed to 37°C (the 
transitioning temperature) and 30°C (the non-transitioning temperature). This information 
provides the foundation for Specific Aim 2.     
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Specific Aim 2:  To determine the ability of ferulic and gallic acids, as 
isolated compounds, to target the oxidative phosphorylation enzymes as a means 
to suppress 25-50% or more of the hyphal stage using the two pathogenic 
Candida strains (SC5314 and A72). The working hypothesis for this specific aim is that 
different phenols will affect the oxidative phosphorylation chain, which will be reflected in 
the hyphal phenotype. This specific aim will be accomplished by treating C. albicans with 
each of the cited phenols in isolation and then measuring the activity of each oxidative 
phosphorylation enzyme in response to C. albicans during its yeast-to-hyphae transition.  
3. MATERIALS AND METHODS: 
3. A. Specific Aim 1:   
3. A.1 Preparation of C. albicans culture: C albicans strains SC5314 and A72 
were obtained from Kenneth Nickerson, University of Nebraska – Lincoln.  A stock 
culture was grown to the stationary phase in Yeast extract-Peptone-Dextrose medium at 
30 °C, washed and stored in potassium phosphate buffer (pH 6.6) at refrigerated 
temperatures. To transition the yeast-to-hyphae, the culture, at a cell density of 1X107 
per mL, was transferred to an Erlenmeyer flask containing 0.65mL of 0.1 M N-
acetylglucosamine (GlcNAc), 2.80 mL of 0.1 M imidazole buffer (pH 6.5), 0.75 mL of 0.1 
M MgSO4, 0.65 mL of 0.1 M GlcNAc and 20.80 mL Nano pure water. The culture was 
then incubated at 37 °C in a water bath with shaking at 300 rpm to achieve aeration for 6 
hr.  A negative control was also prepared as cited above; only the temperature was 
maintained at 30oC to prevent transition.  Aliquots (100 µl) of the cells were collected 
during the course of the transition period at 0, 1, 3 and 6 hr., and the cells from a 100 µL 
aliquot were counted at each time point using a hemocytometer. As the hyphae form 
tends to clump together making counting difficult, the number of hyphae cells vs. yeast 
cells were estimated by subtracting the number of yeast cells counted at each time point 
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(YC) from the number of initial cells (IYC) (at 0 h). Percent inhibition was then calculated 
using the formula: (YC / IYC) * 100 (Camara 2015).   
3. A.2 Enriched Mitochondrial Preparation from C. albicans: Mitochondria of C. 
albicans were obtained from each cited transition time point were isolated from the pellet 
as described by Frazier (2012). Briefly, cells were suspended twice in a solution of 2 mM 
HEPES, 0.1 mM EGTA, 250 mM sucrose, pH 7.4 (with KOH) and then disrupted with a 
Mini-Beadbeater-1 for 3 min. The homogenate was transferred to an Eppendorf tube and 
spun at 600 x g in a chilled centrifuge for 10 min. The supernatants were combined and 
spun in a refrigerated tabletop centrifuge at 14,400 RCF for 10 min. The pellet containing 
enriched mitochondria was re-suspended in 2 mM HEPES, 0.1 mM EGTA, 250 mM 
sucrose, pH 7.4 (with KOH). Approximately 60–75 µL of the suspension was retained for 
CII + III and CIII assays. The remainder was treated with 25 mM potassium phosphate 
buffer (KPI), pH 7.2, 5 mM MgCl2 for the CI, CII, CIV, CV and CS assays as described 
below. Samples were treated to three freeze/thaw cycles in a dry ice/ethanol slurry, to 
disrupt the mitochondrial membranes in order to make the substrates available to 
enzymes.  
3. A.3. Citrate Synthase (CS) Assay:  Citrate synthase (CS) buffer was prepared 
by combining 22.5 mL of 50 mM KPi (pH 7.4), with 2.5 mL of 0.1 mM, 5, 5’-dithiobis-
dithio-bis-(2-nitrobenzoic acid) equilibrated to 30°C. The CS buffer (475 µL) was 
delivered to two matching UV cuvettes. The sample (20 L) was then added to both 
cuvettes followed by 5 µL of acetyl CoA. The reaction was started by adding 5 µL 
oxaloacetic acid in one cuvette, while the other cuvette served as a blank.  The reactions 
were monitored for 3 min at an absorbance at 412 nm. The results were calculated using 
Beer’s law with the extinction coefficient for thionitrobenzoate anion of 13.6/mM/cm.  
3. A.4 Complex I (CI) Assay: The buffer for the CI assay was prepared with 23 
mL of 50 mM KPi (pH 7.4), 0.626 mL of 50 mM nicotinamide adenine dinucleotide, 0.5 
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mL of 1 mM KCN, 0.5 mL of 10 mM antimycin A, 0.25 mL of 0.1% (w/v) bovine serum 
albumin, 0.125 mL of 50 mM coenzyme Q1 and equilibrated to 30 °C. An aliquot of CI 
buffer (475 µL) was delivered to two UV cuvettes, while rotenone (5 µL) was added to 
one cuvette and ethanol (5 µL) was transferred to the other cuvette to serve as a blank. 
The reaction was started by adding 20 µL of the sample to each cuvette. The 
absorbance was measured at 340 nm for 3 min, and the results were calculated with an 
extinction coefficient for NADH of 6.81/mM/cm. 
3. A.5 Complex II (CII) Assay: The CII assay buffer was prepared with 21.5 mL of 
50 mM KPi (pH 7.4), 2.5 mL of 10 mM sodium succinate, 0.5 mL of 1 mM KCN, 0.5 mL 
of 10 mM antimycin A, and 0.25 mL of 2.5 mM rotenone and equilibrated to 30 °C. The 
CII buffer (485 µL) was delivered to two UV cuvettes followed by 10 µL of a sample and 
incubated for 10 min at 30oC. The reaction was started by adding 5 µL of 50 mM CoQ1 
in one cuvette, while 5 µL of 50 mM ethanol was added to second to serve as a blank. 
The reaction was monitored for 3 min at an absorbance of 280 nm, and the results were 
calculated with an extinction coefficient for CoQ1 of 12/mM/cm.  
3. A.6 Complex II + III (CII+III) Assay: The CII + III assay buffer was prepared 
with 21.6 mL of 50 mM KPi (pH 7.4), 2.5 mL of 10 mM succinate, 0.5 mL of 1 mM KCN, 
2.5 mL of 0.25 µM rotenone, 0.25 mL of 0.1% (w/v) BSA, and 0.188 mL of 0.075% 
ethylene diamine tetraacetic acid (EDTA), pH 7.0 and equilibrated to 30°C. An aliquot of 
CII+III buffer (472 µL), 10 µL sample and 5 µL of 1 mM ATP were then added 
respectively to each of two cuvettes and incubated for 5 minutes at 30 °C. The reaction 
was started by adding 12.5 µL of 50 mM cytochrome c to one cuvette, while the solution 
in the other cuvette served as a blank. The reaction was measured at absorbance 550 
nm for 3 min, and the results were calculated with an extinction coefficient of reduced 
cytochrome c of 18.7/mM/cm.  
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3. A.7 Complex III (CIII) Assay: The CIII assay buffer was prepared with 23 mL of 
50 mM KPi (pH 7.4), 1 mL of 1 mM n-dodecylmaltoside, 0.5 mL of 1 mM KCN, 0.25 mL 
of 2.5 mM rotenone, and 0.25 mL of 0.1% (w/v) BSA and equilibrated to 30°C. The CIII 
buffer (480 µL), 5 µL of sample and 5 µL of 0.1 mM (decylbenzylquinol) (reduced DB) 
were added to one visible light cuvette in the cited order. The CIII buffer and reduced DB 
were combined in the second cuvette to serve as a blank.  The reaction was started by 
adding 3.7 µL of 15 mM cytochrome c.  After the 20-second incubation time, the reaction 
was monitored for 3 min at 550 nm, and then L-ascorbic acid was added to the stop the 
reaction. The reaction was measured at absorbance 550 nm for an additional 3 min, and 
the results were calculated with an extinction coefficient for reduced cytochrome c of 
18.7/mM/cm. 
3. A.8 Complex IV Assay:  The buffers 50 mM KPi (pH 7.4) (435 µL) and 2.5 mM 
n-dodecylmaltoside (50 µL) were added to each of two visible cuvettes and equilibrated 
to 30°C.  The sample (10 µL) was delivered to one of the cuvettes and reaction was 
started by adding 3.8 µL of 15 mM of reduced cytochrome c. At the end of 3 min of 
incubation, a few grains of K3Fe(CN)6 was added to the reaction, which was then 
monitored for an additional 3 min at absorbance 550 nm. The results were calculated 
with an extinction coefficient for reduced cytochrome c of 18.7/mM/cm. 
3. A.9 Complex V Assay: The V assay buffer was prepared with 21.25 mL of 40 
mM Tris–HCO3, 1 mM EGTA (pH 8.0), 2.5 mL of 0.2 mM NADH, 0.625 µL of 2.5 mM 
phosphoenolpyruvate (PEP), 0.25 µL of 0.5 mM antimycin A, 0.125 µL of 5 mM MgCl2, 
0.125 µL of 50 mg/ml lactate dehydrogenase (LDH), and 0.125 µL of 50 mg/ml pyruvate 
kinase (PK) equilibrated to 30°C. The V buffer (477.5 µL) and 12.5 µL of 2.5 mM ATP 
were added and allowed to equilibrate for 2 min. The reaction was started by adding 10 
µl sample in one UV cuvette, while the other cuvette served as blank containing 10 µl of 
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2 µM oligomycin. The reaction was measured at absorbance 340 nm for 3 min. The 
results were calculated with an extinction coefficient of 6.22/mM/cm for NADH.  
3. A.10 Protein Assay:  The Bradford protein assay was used to a measured 
protein concentration of 150 µL of C. albicans, which was collected at 0, 1, 3 and 6 hr 
during the yeast-to-hyphae transition.  One hundred µl Coomassie Brilliant Blue G-250 
was added to the samples along with 50 µL of 50 mM KPi (pH 7.4) and allowed to 
incubate for 10-30 min. The reaction was measured in the microplate reader at 595 nm, 
and the protein levels were measured using bovine serum albumin as the standard. 
3. A.11:  Activity Calculations used for each Assay (3. A.3-9):  The activity for a 
given enzyme was determined from the data obtained from the associated assay and 
the protein levels as defined by the following equation: activity = (Δ Abs * V) / (ɛ * L * v 
*[prot]) in nmol /min/ mg where ɛ is extinction coefficient, V is reaction volume, v is 
sample, and [prot] is protein concentration of C. albicans. 
3. B. Specific Aim 2:   
3. B.1 Culture Transition with a Single Treatment:  The yeast cells were prepared 
for transition as described in Section 3.A.1.  For this Specific Aim, each phenolic acid 
(ferulic and gallic acid) were prepared fresh, but in isolation, in 2% ethanol (v/v), as 
screening studies also using various concentrations of methanol and dimethyl sulfoxide 
showed this organic solvent at the designated concentration effectively solubilized the 
phenols but did not affect C. albicans transition (data not shown).  The treatment solution 
was added to N-acetylglucosamine differentiation media at 5-7 final concentrations with 
the upper level soluble in 2% ethanol. The cells were allowed to transition, counted and 
percent inhibition determine as described previously.  
3. B.2 Enriched Mitochondrial Preparation from C. albicans cultures:  The 
samples collected from the B1 experiments were then handled and tested as described 
in 3A.2 to 3A.11.  
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 3. C   Statistical Analyses: 
A factorial design was used for analysis of the individual compound experiments 
with replication, time and compound as factors. The % inhibition data were obtained 
from at least three repetitions of each experiment, which includes the yeast-to-hyphae 
transition, and every phenolic treatment. The enzyme activities and % inhibition were 
expressed as the mean +/- standard deviation.    One way ANOVA was applied to the 
results by using the with Tukey's honestly significant difference test to evaluate the 
significance of the mean of the data concerning the transition period (0,1,3 and 6 hours) 
and the negative control for untreated and treated samples with different enzymes. The 
results were considered significant at p < 0.05.  The Grub’s test was used to determine 
data outliers at the 95% confidence interval.  
4. Results and Discussion: 
4. A. Specific Aim 1:  Activities of the oxidative phosphorylation enzymes of C. 
albicans (SC5314 and A72) during the transition from yeast to hyphae:  
The enzymes of oxidation phosphorylation (OXPHOS), which include the 
electron transport (ECT) enzyme complexes (I, II, III, IV,) and the OXPHOS enzyme (V), 
synchronize their activity in order to effectively produce the potent energy molecule, 
adenine triphosphate (ATP), during normal respiration. Such synchronization is critical 
considering that these enzymes play the major role in producing the majority of ATP for 
a cell and thus collectively for a whole organism. As is expected, dysfunction or inhibition 
of one or more of these complexes will affect their harmonization leading to stress and 
even damage to the mitochondria, their site of location (Frazier and Thorburn, 2012).  
Mitochondrial dysregulation can, in turn, potentially affect one or more tissues that can 
progress into multisystem disorders that disregard age group, gender or ethnicity 
(Munnich and Rustin, 2001; McFarland et al, 2010; Di Donato, 2009).  Indeed, mutation 
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in 100 genes have been identified in mitochondrial related diseases, which predicates 
that 1 in 5000 people will be affected by the most common cause of inborn metabolism 
errors (Skladal, 2003, Wong et al., 2010, Tucker et al, 2010,  Kirby and Throburn, 2008).    
 Among these conditions, disturbing the OXPHOS mechanism can result in the 
changes to the morphology of the affected tissue organs. Torii et al. (1992) determined 
that the enzymes CI and CIV were both decreased in aging rats in the mitochondria of 
muscle tissue, , but not in other organs, such as the heart and liver. Boffoli et al. (1994) 
further showed a significant decrease in the enzymatic activity of Complex CI, CII and 
CIV in the human skeletal muscle of orthopedic patients, which was attributed to a 
decline in mitochondrial respiration. The authors further hypothesized that decreased 
activity of CI, CII and CIV enzymes was also involved in the structural and functional 
decline of the muscles and tissues associated with aging. Moreover, Bowling et al. 
(1993) reported that the damage that occurred to mitochondrial DNA in the brain tissue 
of aging monkeys was directly caused by a decrease in the activity of CI and CIV 
whereas CII+III and CV did not show significant differences. Combined, these studies 
demonstrate that a change in activity of one or more of OXPHOS enzymes can critically 
impact the phenotype of a cell or tissue leading to organ damage even when the other 
OXPHOS enzymes are operating properly (Frazier and Thorburn, 2012).  
Other more current studies have shown that OXPHOS related defects are most 
common in cells or tissues with high energy demands, such as skeletal, neuromuscular 
or central nervous systems (Rahman and Hanna, 2009, Finsterer, 2006). Considering 
that cancer cells are metabolically adapted for rapid growth and proliferation, Rossignol 
et al (2004) studied the effects of OXPHOS and glycolytic respiration in a cervical cancer 
lines (HeLa) versus their normal cell counterparts to determine if a specific substrate 
availability played an important role in the respiration of the cancer cells. This research 
was particularly relevant for cancer cells as energy is primarily generated by glycolysis 
24 
 
 
(the Warburg effect) rather than OXPHOS (Vander Heiden, 2009). In this study, the 
expression of the OXPHOS proteins were down-regulated in the presence of glucose as 
was expected by the researchers. However, when galactose served as the energy 
substrate, OXPHOS enzymes were up-regulated indicating that respiration could be 
modulated to a more healthy state, even in cancer cells, when subjected to a different 
substrate.   
All cells must respond to changes in respiration due to the availability of various 
substrates to maintain adequate energy levels (Calderone and Fonzi, 2001). C. albicans 
is not exempt from this circumstance.  But, when certain cues in the environment require 
that these cells switch from yeast to hyphae, the ability of C. albicans to readily adapt 
metabolically to transition that may be similar to that cited for the cancer cells (Rossignol 
et al., 2004) due to the rapid response required. Therefore, it is critical to study the 
OXPHOS energy demand on C. albicans in an effort to understand how energy 
modulates this switch. This information could thus lead to a potential target for 
alternative and viable treatment options.  
4A.1 Cell morphology during yeast to hyphae transition.   
Figure 7 shows the morphology of phenotypic switch of C. albicans (SC5314) 
during 0, 1, 3 and 6 hr. These time points were selected as studies in our laboratory 
determined that C. albicans is biochemically active even if the morphology appears 
similar during certain stages of the transition process (data not shown). At 0 and 1 h, the 
cells were round to ovoid shape, albeit the latter were starting to adhere to one another 
(yet another virulence factor) (Calderone and Fonzi, 2001). Most of the cells had 
transitioned to the germ tube form by 3 h, with ~75%+ reaching the hyphal form. At 6 hr, 
the cell were 95% hyphae with longer and wider filaments that included high cell 
adhesion. It must be noted that the transition images of only C. albicans (SC5314) are  
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Figure 7:  Morphology of C. albicans (SC5314) during the course of the phenotypic 
switch from a benign yeast to adhesive hyphae.  
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presented here in as C. albicans (A72) showed similar morphologies under similar 
conditions (shaking at 37oC and using glucosamine media).  
4A.2 Comparison of C. albicans (strain A72 vs. SC53134) OXPHOS enzyme activity 
during yeast to hyphae transition at 0, 1, 3 and 6 hr. 
Because the morphologies appeared similar between C. albicans A72 vs 
SC53134 during the switch, the activities of each enzyme at transition time points (0, 1, 
3 and 6 hr) were compared to each other to determine if differences occurred at the 
molecular level on a strain by strain basis.  Such information is significant to understand 
whether different treatment options are necessary for different pathogenic Candida 
strains in terms of targeting OXPHOS enzyme activity to prevent the yeast to hyphae 
switch.  To more accurately make such comparisons, the tricarboxylic acid (TCA) 
enzyme CS, which is also located in the mitochondria, was monitored to serve as a 
reference point for mitochondrial activity.  By expressing the activity of each of the 
OXPHOS complexes as a ratio to CS activity, variability that may result from differing 
cell culture conditions (i.e. cell passage number or cell confluence) or even mitochondrial 
proliferation, which is typical in elongating C. albicans hyphae, can be prevented.  
Moreover, as different assays are displayed on the same graphic, each enzymatic value 
obtained at each hour was normalized to a given strain that was subjected to the non-
transitioning condition, i.e., 30 oC (Figure 8 a-d), and was deemed the negative control.  
It also must be noted that the CI enzyme was not included in any of the analyses as no 
significant differences occurred in the activity of this enzyme regardless of strain type or 
time point throughout the transition.  These results indicate that this sole OXPHOS 
enzyme, CI, does not differentially affect C. albicans respiration leading to the yeast-
hyphae switch, but most likely continues to establish a potential across the inter-
membrane and inner membrane space throughout the transition period.   
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Figure 8. a and b. Statistical analysis of each enzyme for each strain, A72 (blue) and 
SC5314 (orange) at 0 hr (a) and 1 hr (b).  Bars with different letters show significance for 
two strains based on a given enzymatic values only P< 0.05.  All values were normalized 
to the negative control, which was set at 0.00, as represented by the bold grey line.    
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Figure 8. c and d: Statistical analysis of each enzyme for each strain, A72 (blue) and 
SC5314 (orange) at 3 hr (c) and 6 hr (d).  Bars with different letters show significance for 
two strains based on a given enzymatic values only P< 0.05.  All values were normalized 
to the negative control, which was set at 0.00, as represented by the bold grey line.    
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In terms of both enzyme activity and transition hr, it is clear the OXPHOS 
respiration of the two strains differ despite similar morphologies over the course of the 
transition (Figure 8). (It must be emphasized that bars with associated letter indicate 
significance of the two strains relative to only a given complex rather than all the 
complexes). Although the respiration of two species of C. albicans yeast, i.e., C. albicans 
and C. parilosis, have been monitored (Calderone and Clancy 2011), strains to strains 
differences have not been discussed in the literature to our knowledge, nor has 
OXPHOS enzyme activities been analyzed throughout the phenotypic switch of C. 
albicans. In this study, the results show that significant differences between most of the 
OXPHOS enzymes exhibited by the two strains (SC5314; SC) and (A72) regardless of 
transition time point (Figures 8 a-d) with the notable exception of the 0 hour time point 
(Figure 8 a). For the latter time points, the activity of CII + CIII expressed by SC was ~10 
fold higher relative to that exhibited by A72. These results from the combined enzymes 
represents the transfer of electrons from CII to CIII where the reduction of cytochrome c 
occurs. The activity of the terminal enzyme of ETC (CIV), i.e., the site where cytochrome 
c is oxidized while generating water, was also statistically different between strains A72 
and SC5314. The enzyme activity exhibited by SC5314 is lower than its A72 counterpart 
most likely as a means to regain homeostasis due to the increased electron transfer 
from CII and CIII as CV is statistically similar between the two organisms again (Figure 
8a). Activation of CII+CIII may by may be an initial response of SC5314 to the new 
transition media considering that the cells were still in the yeast state and had just been 
transferred to a new environment (Calderone and Fonzii, 2001). Still, the values for all 
the enzymes are relatively low and trend near that of the baseline of the negative control 
for the 0 hr time point (Figure 8a).  
However, by the 1 hr time point (Figure 8b), the values for all of the complexes 
were significantly different from each other, indicating that respiration readily changes 
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between the strains as they transition between the two phenotypes early in the process.  
More specifically, the activity for most of the complexes relative to C. albicans (SC5314) 
increased dramatically, i.e., from trending along the negative control to increasing to a 
high of 105, particularly for CII, CIII and CII+CIII (Figure 8b). These results indicate that 
electrons are being moved quickly through the ETC. However, at the 1 hour transition, 
the morphology of the yeast has not changed dramatically (Figure 7), but adhesion has 
initiated. Although the values for strain A72 do not even register on the bar graph (figure 
8b) due to the elevated activities of strain SC5314, most of the associated enzymes 
increased by 10 fold with the notable exception of CIV, which remained close to 
baseline. For strain SC5314, CIV increased by a 2-fold factor. As such, even though 
substantially higher activities were exhibited by strain A72, a similar trend occurred 
across the enzymes for both strains.   
When the yeast had transitioned by 3 hr mostly to the hyphae from (Figure 8c) 
the activities for both A72 and SC5314 began to reduce for all of the enzymes, which 
again show similar trends, but yet the two pathogenic C. albicans strains are statistically 
different relative to each enzyme activity due mainly to the higher activities produced by 
strain A72. Although additional virulence factors were expressed, as evidenced by the 
clumping effect (Figure 7) that is most likely due to the formation of biofilms and 
adhesion of cells and both strains exhibited elongated hyphae, no trend existed between 
the activities of the complexes (Figure 8d) across species. Indeed, the activity levels of 
enzymes for strain A72 were substantially higher than those expressed by strain 
SC5314, with the notable exception of CII + CIII, and CIII, where the activities of A72 
were slightly but significantly lower than those expressed by its counterpart.  Lastly, the 
activities decreased by 2-3 fold for most but not all of the A72 enzymes, except CIV 
remained at the same level as that expressed at 3 hr (Figure 8c). These results again 
show that respiration is acting much differently between the two strains at time point 6 hr  
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Figure 9, a, b, c.  Activity of Complex II (a.), Complex II + III (b.) and CIII (c.)  for C. 
abicans (A72) at 0, 1, 3 and 6 hr post-innoculation.  Bars with different letters are 
significant across time period (p < 0.05). All values were normalized to the negative 
control, which was set at 0.00, as represented by the bold grey line. * represents an 
enzyme at a given time that is statistically different than the negative control.       
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Figure 9 d, e.  Activity of Complex IV (d.), and CV (e.)  for C. abicans (A72) at 0, 1, 3 and 
6 hr post-innoculation. Bars with different letters are significant across time period (p < 
0.05).  All values were normalized to the negative control, which was set at 0.00, as 
represented by the bold grey line. * represents an enzyme at a given time that is 
statistically different than the negative control.       
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as the most of the enzyme activity now differs not only in intensity but in the overall trend 
that was exhibited during the 1 and 3 hr transition period. Thus, if OXPHOS was to be 
used a potential target for inhibiting the yeast to hyphae transition, different treatment 
options for different strains most likely are warranted. 
4. A.3 Comparison of C. albicans (strain A72) OXPHOS enzyme activity during 
yeast to hyphae transition at 0, 1, 3 and 6 hr.   
Based on the data discussed above, the activities of each enzyme for a given 
strain were analyzed across time to determine certain points (complexes) that could 
serve as potential targets (Figure 9.a-e). In these experiments, the activities were again 
statistically normalized to CS and then normalized to the control. This data was also 
evaluated to determine whether it was statistically different. 
During time 0 of the transition (Figure 9 a-e), most of the complexes were 
statistically different than the negative control, with the notable exception of CII and CIV 
(Figure 9 a, d). The former complex obtains electrons from CI via the oxidation of the 
Coenzyme Q hub located in C albicans, which then enables CII to catalyze the oxidation 
of succinate to fumarate and the reduction of Coenzyme Q (Deepu, et al. 2012).  This 
complex does not participate in electron transfer but has been linked to reducing 
powerful reactive oxygen species (ROS) (Ward, 2015). Therefore, CII may not yet have 
been actively subjected to the presence of ROS considering the time point was only 0 hr.  
However, as the time increased to 1 hr, the activity of this enzyme increased by 5-fold 
indicating that the transition is taking place and that the CII is suitably activated to 
protect C. albicans against ROS during the transition (Figure 9a). Indeed, by 3 hr, the 
activity decreased below the control when most of the yeast switched to hyphae. These 
results suggest that the ROS generation was complete, or that the ROS overpowered 
34 
 
 
the complex. Still, by 6 hr, CII was again significantly similar to the negative control 
thereby supporting the former hypothesis.     
Referred to as cytochrome c oxidase, CIV (Figure 9d) is the final protein complex 
in the electron transport chain. It is therefore not surprising that this complex was 
statistically similar to the negative control at 0 hour.  And, the substantial increase in 
activity by 1 hr is expected as the organism is in a state where it will need the energy to 
transition fully to the hyphae state and then continue to elongate and produce other 
virulent factors by 3 and 6 hr. Complex V (Figure 9e) showed a similar trend at 1, 3 and 
6 hr, as would be also be expected considering that this complex catalyzes AMP to ATP. 
Interesting, CV was statistically different from the control at time point 0 even though CIV 
was not (Figure 9d and e). A possible reason could be that CV was able to sense the 
establishment of the proton gradient across a membrane to drive the synthesis of ATP 
from ADP and phosphate (Pi).  
Complexes III and II +III (Figure 9 b and c) showed a similar pattern as CIV and 
CV, but their activities were much higher, reaching intensities comparable to CII at the 1 
hr time point. Complex III is also known as cytochrome c reductase (Ward, 2015).  
Because only one electron can be transferred to  the ubiquinol (QH2) donor from CII, 
this step is more elaborate as the enzyme binds three substrates, QH2, cytochrome C, 
and ubiquinone (Ward, 2015). After elaborate cross talk between these sites in the 
exchange of electrons, two electrons are eventually passed to CIV, while gaining two 
protons from the mitochondrial matrix, thereby adding to the proton gradient. Due to the 
number of substrates involved as well as both electrons and protons, the activity most 
likely elevated in order to maintain the flow of incoming electrons as well as the proton 
gradient. By 3 hr, the activity for this CIV is not significant, but it is well after transition of 
the hyphae had appeared (Figure 8). It does become significant again by 6 hr, probably 
to aid in providing the energy needed for elongating the hyphae and producing the other  
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Figure 10 a.b.c.  Activity of Complex II (a.), and CII + III (b.) amd CIII (c.)  for C. abicans 
(strain SC5314) at 0, 1, 3 and 6 hr post-innoculation.  Bars with different letters are 
significant across time period (p < 0.05).  All values were normalized to the negative 
control, which was set at 0.00, as represented by the bold grey line. * represents an 
enzyme at a given time that is statistically different than the negative control.       
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Figure 10 d.e.  Activity of Complex IV (D.), and CV (E.)  for C. abicans (strain SC5314) 
at 0, 1, 3 and 6 hr post-innoculation.  Bars with different letters are significant across 
time period (p < 0.05).  All values were normalized to the negative control, which was set 
at 0.00, as represented by the bold grey line. * represents an enzyme at a given time 
that is statistically different than the negative control.       
 
37 
 
 
virulence factors. As stated previously, the assay associated with Complex II + III 
assesses the coupled transfer of electrons from CII to CIII through the CoQ hub (Deepu 
et al. 2012).  By the 6 hr time period, all the enzymes are at much lower activity levels 
indicating that a high amount of energy is needed for A72 to transition to its yeast form. 
As such, this may very well be the first target for developing a novel treatment approach 
for preventing the transition, namely, to stop CII+CIII as it is the first point of critical 
electron transfer to CIV, the enzyme for the final product, as well as depleting the proton 
pump. 
4A.4 Comparison of C. albicans (SC5314) OXPHOS enzyme activity during yeast to 
hyphae transition at 0, 1, 3 and 6 hr  
Figure 10 a-e shows the OXPHOS effect for Candida albicans (SC5314) for each 
enzyme and time point. Again the transition time points, 0, 1, 3 and 6 hr were compared 
with each of the enzyme activities expressed by the OXPHOS enzymes. Moreover, the 
enzymatic activities of the transitioning cells were normalized of those that did not 
transition but were subjected to the same media.   
At the 0 hr time point, three enzymes were statistically similar to the negative 
control, and included CII, CII+CIII and CV (Figure 10 a, b, e). With the exception the CV, 
the 0 hr time point did not vary in terms of activities between the control and the cited 
enzymes. Although CV was not significantly different than the control for strain SC5314 
(Figure 10e), the activity was slightly but statistically higher compared to strain A72 
(Figure 9e). We attributed this phenomenon to sensing of the proton gradient (refer to 
Section 4.A.3). However, by 1 hr, CV was significantly different from the control (Figure 
10e). Moreover, CII was not significantly different at any of the transitioning time points, 
0-3 h (Figure 10a). As this reaction is important for controlling ROS, these unchecked 
free radicals may have been in abundance, although their levels require measurement to 
test this hypothesis. In addition, CII + III (Figure 10b) was not statistically different at 
38 
 
 
either the 1 or 3 hr time point, probably due to the lower activity of CII (Figure 10a). Yet, 
electron transfer did occur as CIII was active at 0, 1, 3 and 6 hr indicating that this strain 
may have bypassed CII (Deepu 2002) and shuttled the electrons from CI directly through 
the CoQ hub into CIII, which also would explain the reason that CIV activity was 
statistically low at 0 hr as the electrons may have been overwhelming this enzyme even 
by bypassing CII and CII + III even at 0 h. But by 1 hr the final product was most likely 
being produced, as the activity of CIV and CV increased (Figure 9d and e). Yet, by 3 hr, 
the activities of all the enzymes are similar to the control, i.e., after the transition has 
occurred, but are statistically different at 6 hr when the hyphae elongate, and other 
virulence factors are formed. Based on the data, the other virulence factors may require 
more energy than the transformation from this strain.  As such, in this strain it may not 
be as difficult to prevent the phenotypic switch, as the energy may be conserved for 
producing virulence factors that occur later in transition. It must be noted that although 
the enzyme activities are much lower for strain SC5314 compared to its counterpart, the 
event itself may occur more quickly if indeed CII is not involved.     
4. B. Specific aim 2:  To determine the ability of gallic and ferullic acid, as isolated 
compounds, to target the oxidative phosphorylation enzymes as a means to 
suppress 25-50% or more of the hyphal stage transition using the two C. albicans 
strains (SC5314 and A72). 
Research is currently in progress for developing new drugs that are effective 
against C. albicans virulence as a means to reduce or prevent the effect of invasive 
candidiasis. However, most antifungal agents are either toxic or drug resistance exists 
(Ghannoum and Rice, 1999). Moreover, drug studies that target the virulence factors of 
C. albicans are essential considering that this is a benign commensal yeast when not 
virulent. Destroying the non-virulent microbe just opens a niche for potentially a more 
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dangerous organism. These types of studies remain limited but do include phenolic 
compounds, which have been shown to have antimicrobial activity, including preventing 
the hyphal form. For example, Saito et al., 2013 showed that 2.8 mM of catechin was 
able to inhibit the hyphal formation of C. albicans (NUD-202) isolated from the human 
mouth by reducing mRNA expression levels of hypha-specific genes and disrupting the 
MAP kinase cascade. In this study, the effect of phenolic acids, ferulic and gallic acid as 
isolated compounds on inhibiting the yeast-to-hypha transition were monitored for the 
two strains of C. albicans (SC5314 and A72). These phenolic acids were selected for 
this study as both were determined to be the most effective phenols in inhibiting the 
phenotypic switch of the phenols tested to date in our laboratory.   
4. B.1. Dosage Selection of each Phenol 
The time selected to monitor the ability of the cited phenols to act upon OXPHOS 
complexes were correlated with the yeast to hyphae transition (Figure 11), which was 0, 
1, 3 and 6 h. However, the concentration which was able to inhibit the yeast the longest 
and / or had the greatest effect was determined before proceeding any with the OXPHOS 
enzyme experiments. 
 As such, different concentrations of the phenolic acids were prepared that 
included 4, 2, and 0.4 mM. Aliquots of each solution (Table 1 and Table 2) was added to 
the transition media and the inhibition was monitored as described in the Materials and 
Methods section. Each of these concentrations were able inhibit the yeast-to-hyphal 
transition up to 92% within 3 hr for C. albicans (SC5314), and up to 86% within 3 hr for 
C. albicans (A72), which agreed with other published papers. For example, a previous 
study completed in our laboratory demonstrated that 95% of C. albicans (SC5314) 
remained in the yeast form for 3 hr in the presence of 3.5 mM catechin, with GlcNAc 
serving as inducing agent (Camara, 2015). Also, 50% of C. albicans (SC5314 and A72) 
were clearly in the yeast form 4 hr post-inoculation into in N-acetyl glucosamine using  
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Table 1 
 Comparing hyphae inhibition (%) by different concentrations of Gallic acid in 
different time points in the two C. albicans (SC5314 and A72). 
 
 
                                  Gallic  Acid (mM) 
                  A 27                   SC5314 
 Time  0.4 mM 2 mM 4 mM 0.4 mM 2 mM 4 mM 
1 hr 81.5% ± 4.9 35.9% ± 1.3 87.4% ± 7.2 39.0% ± 1.3 21.0 %± 0.9 16.8 %± 0.5 
3 hr 4.9 %± 0.4 7.3% ± 0.7 14.0% ± 2.5 2.5 %± 0.4 3.1 %± 0.9 4.4 %± 0.7 
6 hr 2.0% ± 0.4 4.5% ± 0.8 9.4% ± 3.3 0.7 %± 0.3 1.9 %± 0.5 2.9 %± 0.4 
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Table 2 
Comparing hyphae inhibition (%) of different concentrations of Ferulc acid in  
different time points in the two C. albicans (SC5314 and A72). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Ferulic Acid (mM) 
 A 27 SC5314 
Time 0.4 mM 2 mM 4 mM 0.4 mM 2 mM 4 mM 
1 hr 86.9% ± 2.5 42.9 %± 3.6 89.4 %± 3.3 50.6% ± 3.3 
                 
49.9 %± 2.1 23.9 %± 0.6 
3 hr 5.2% ± 0.9 8.7% ± 0.8 12.2 %± 0.9 4.8% ± 0.4 7.7% ± 0.7 2.6% ± 0.3 
6 hr 1.1% ± 0.6 3.3% ± 0.4 5.0% ± 0.9 1.5% ± 0.2 3.6% ± 1.0 1.9% ± 0.2 
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different concentrations of farnesol (1-250 µM farnesol) (Mosel et al. 2005). 
Another study showed that C. albicans (SC5314) reduced the yeast-to-hyphae transition 
when exposed to (200-900 µM) resveratrol for 60-300 min using different serum, pH, and 
nutrient-induced conditions (Okamoto-Shibayama et al. 2010). These results indicate 
that C. albicans has the flexibility to respond to different strains due to their ability to 
metabolize available nutrients from other natural habitats present in inhabiting the host 
(Brown and Gow 1999). Another point of note from these studies is that strain A72 was 
the most responsive to both the ferulic and gallic acid treatments early into the transition 
period by delaying the onset of the hyphae formation.  
The lowest gallic / ferulic acid dosages used in this experiment produced the 
highest inhibition effects while decreasing and then increasing with increasing 
concentration for the strain A72. For strain SC5314, inhibition indirectly correlated with 
concentration, whether it be gallic acid or ferulic acid serving as the treatment. This is 
not an uncommon phenomenon, otherwise known as the low treatment effect 
(Casagrande and Darbon, 2001). Other researchers have reported similar but atypical 
responses for cells exposed to low doses of pure natural agents. For example, a cancer 
study resulted in cell viability that initially increased and then decreased; increased and 
decreased again with higher treatment doses. Casagrande and Darbon (2001) attributed 
such results to the ability of biological systems to be overcome by the low level toxicity of 
a bioactive agent while they are able to compensate at higher doses. Other studies 
completed in our lab have shown similar effects of a virulent factors, i.e., adhesion and 
biofilm formation, in that the lower concentrations tend to be the more potent the 
treatment (data not shown). More studies are needed to understand this low-dose 
response as these results may have important clinical implications.   
4. B. 2 Effect of phenols on the oxidative phosphorylation enzymes. 
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As stated previously, phenolic compounds can act upon multiple carbohydrate 
metabolic pathways (Arathi and Sachdanandam, 2003; Kueck et al., 2007; Suolinna et 
al., 1975), including the electron transport chain. Indeed, phenolic compounds have 
shown potent effects on the generation of ATP. To this end, Morelnd and Novitzky 
(1987) showed that the phenols (coumarins, cinnamic acids, and vanillin) were active in 
in facilitating the ATP generating pathway by using 1-20 mM concentrations. The results 
also showed that higher concentrations lowered enzyme activity.  Makovec and Šindelář 
(1984) determined that phenolic compounds (20 mM final concentration) affected the 
activity of respiratory chain enzymes of potato tuber mitochondria. Indeed, the 
researchers reported that gallic acid and quercetin significantly inhibited cytochrome c 
oxidase (Complex IV) by 72% of the control, while succinate dehydrogenase (complex II) 
was significantly inhibited by cinnamic and caffeic acid. On the other hand, reports have 
shown that phenolic compounds can have a negative impact on ATP generation by 
inhibiting the electron transport chain and OXPHOS (Moreland and Novitzky, 1987). The 
study showed that polyphenolic rich extracts obtained from chloroplasts (1 and 20 mM) 
significantly inhibited NADH oxidation and succinate dehydrogenase activity, or CI and 
CII respectively. Although the respiratory system of yeast, such as C. albicans, and 
plants differ, with the later missing the alternative oxidase (AOX) and parallel respiratory 
(PAR) pathways, both share the classical respiratory complex (CRC) pathway (Odds, 
1988). To this end, Konishi et al. (1987) determined that 200 µg/ml tannic acid was able 
to inhibit the NADH dehydrogenase (CI) and the terminal oxidase (cytochrome b560-d 
complex) of the respiratory chain of Photobacterium phosphoreum.   
In this study, the effect of isolated phenolic compounds on OXPHOS complexes  
(CII, CII+III, CIII, IV, V) present in C. albicans (SC5314 and A72) on the yeast to hyphal 
transition were investigated and correlated to the yeast morphology at a given time point 
(0, 1, 3 and 6 hr). As stated previously, gallic and ferulic acid were the most efficacious  
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Figure 11 a,b,c.  Effects of Gallic Acid on the activity of Complex II(a.), III (b.) CII + III) 
(c.) C. abicans (strain SC5314) at 0, 1, 3 and 6 hr post-innoculation.  Bars with different 
letters are significant across time period (p < 0.05).  All values were normalized to the 
negative control, which was set at 0.00, as represented by the bold grey line. * 
represents an enzyme at a given time that is statistically different than the negative 
control.       
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Figure 11 d.e.  Effects of Gallic Acid on the activity of Complex VI (d.), and CV (d.) C. 
abicans (strain SC5314) at 0, 1, 3 and 6 hr post-innoculation.  Bars with different letters 
are significant across time period (p < 0.05).  All values were normalized to the negative 
control, which was set at 0.00, as represented by the bold grey line. * represents an 
enzyme at a given time that is statistically different than the negative control.       
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compounds among the individual phenols tested in our lab to inhibit the yeast to 
hyphae transition.  Therefore, these compounds were used for further studies to determine 
their ability to act upon the OXPHOS enzymes as possible target to mitigate the phenolic 
switch. 
4. B. 3 Effects of gallic acid during C. albicans (SC5314 and A72) yeast-to-hyphae 
transition on the oxidative phosphorylation enzymes. 
Figures 11 and 12 show the effect of gallic acid on C. albicans (SC5314 and 
A72) during the yeast-to-hyphae transition on OXPHOS, respectively. First, for strain 
SC5314, respiration shifted to increased activity for all the enzymes at the 3 hr transition 
point rather than what was typically the 1 hr point for the (untreated) positive control 
(Figure 11). Additionally, at 0 hr and 1 hr, CV enzyme was comparable to the negative 
control while the other enzymes, at time points 0, 1, and 6 hr, were low but statistically 
significantly different from the negative control. These results suggest that gallic acid 
may lead to reprogramming respiration. Although hyphae were fully present at 3 hr, 
other virulence factors could have been affected, as it proposed that high activity of the 
CV enzyme postive control (Figure 10e, 6 hr time point) continued to produce  
presumably for developing biofilms and other virulence factors. It must be emphasized 
again that by 1 hr, the activity of CV of cells treated with gallic acid was statisically 
comparable to the negative control indicating that no energy was being produced for the 
phenotypic switch at this time.  Based on these data, the following hypothesis can be 
made. In the prescence of gallic acid, the duration of the switch from yeast to hyphae 
lengthend or shifted from 1-3 hr to 3+ hr with other viurlence factors most likely 
negatively impacted. However, Table 1 nullifies this hypothesis, as the inhibitory rate is 
only 2.5% at the 3 hr time point, thereby leaving the other potential negative effects on 
biofilm formation, hyphae elongation and cell adhesion.    
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Figure 12 a,b,c.  Effects of Gallic Acid on the activity of Complex II (a.), III (b.) CII + III 
(c.) C. abicans (strain A72) at 0, 1, 3 and 6 hr post-innoculation.  Bars with different 
letters differ significantly across time period (p < 0.05).  All values were normalized to the 
negative control, which was set at 0.00, as represented by the bold grey line. * 
represents an enzyme at a given time that is statistically different than the negative 
control. 
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Figure 12 d.e.  Effects of Gallic Acid on the activity of Complex VI (d.), and CV (d.) C. 
abicans (strain A72) at 0, 1, 3 and 6 hr post-innoculation.  Bars with different letters differ 
significantly across time period (p < 0.05).  All values were normalized to the negative 
control, which was set at 0.00, as represented by the bold grey line. * represents an 
enzyme at a given time that is statistically different than the negative control.       
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Alternatively, the OXPHOS complexes of C. albicans (A72) showed significant 
differences between 0, 1, 3, and 6 hr, for all the enzymes (Figure 12 a-c) compared to 
the positive control (Figure 9a-B). The most notable difference in activity was that the 
overall intesity of each enzyme was substantially lower than that of either the positive 
control (Figure 9) or the negative control (grey bar on each figure), indicating a longer 
time period for a compete shift from yeast to hypae.  Again,  CV (Figure 12 e) produced 
a low activity, but lower than the negative control. Although the complex could be active, 
it probably could not catalyze enough ATP to sustain a speedy phenotypic switch, 
coupled with the decrease in overall enzyme activity by the complexes. According to 
Table 2, it took 3 hours for 95% of the yeast to form into the hyphal phenotype. These 
results indicate the gallic acid is partially protecting against C. albicans virulence by 
lengthening the time switch and possibly other virulence factors.   
4. B. 4 Effects of Ferulic acid during C. albicans (SC5314 and A72) yeast-to-hyphae 
transition on the oxidative phosphorylation enzymes. 
Ferulic acid was able to temporarily inhibit the yeast- to hyphal transition of C. 
albicans (SC5314 and A72) (Table 2), but was least effective against the SC5314 strain.  
Again, these results could be due to ferulic acid acting on the OXPHOS enzymes as 
most of the activities of the complexes at all the time points (Figure 13 a-e) varied 
substantially from the postive control (Figure 9a-e) while multiple enzyme activies were 
not significantly different than the negative control with the notable exceptions of CII 
(0,1,2 hr), (Figure 13a); CIV (0,1,3 and 6 hr)  (Figure 13 d); and CV (0 and 1 hr) (Figure 
13e). Lastly, (Figure 14 a-d) shows the effects of ferulic acid on transtion C. albicans 
(A72). Similar to C. albicans (SC5314), many of the enzymes at different time points are 
statistically similar to the negative control, with the exception of  CII+ CIII (3 hr), (Figure 
14b); CIII (0,1 and 3 hr); and CIV (0, and 3 hr); (Figure 14d). The data from both ferulic 
acid treaments show that when subjectied to ferulic acid, respiration of C. albicans  
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Figure 13 a,b,c.  Effects of Ferulic Acid on the activity of Complex II (a.), III 
(b.) CII + III (c.) C. abicans (strain SC5314) at 0, 1, 3 and 6 hr post-
innoculation.  Bars with different letters are significant across time period (p < 
0.05).  All values were normalized to the negative control, which was set at 
0.00, as represented by the bold grey line. * represents an enzyme at a given 
time that is statistically different than the negative control.       
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Figure 13 d.e.  Effects of Ferulic Acid on the activity of Complex VI (d.), and CV (d.) C. 
abicans (strain SC5314) at 0, 1, 3 and 6 hr post-innoculation.  Bars with different letters 
are significant across time period (p < 0.05).  All values were normalized to the negative 
control, which was set at 0.00, as represented by the bold grey line. * represents an 
enzyme at a given time that is statistically different than the negative control.       
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Figure 14 a,b,c.  Effects of Ferulic Acid on the activity of Complex II (a.), III (b.) 
CII + III (c.) C. abicans (strain A72) at 0, 1, 3 and 6 hr post-innoculation.  Bars with different 
letters are significant across time period (p < 0.05).  All values were normalized to the 
negative control, which was set at 0.00, as represented by the bold grey line. * represents 
an enzyme at a given time that is statistically different than the negative control 
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Figure 14 d.e.  Effects of Ferulic Acid on the activity of Complex VI (d.), and CV (d.) C. 
abicans (strain A72) at 0, 1, 3 and 6 hr post-innoculation.  Bars with different letters are 
significant across time period (p < 0.05).  All values were normalized to the negative 
control, which was set at 0.00, as represented by the bold grey line. * represents an 
enzyme at a given time that is statistically different than the negative control.       
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(SC5314) appears to slow down at least compared to the negative control, as many 
values fall below the grey line (Figure 13a-d),  and decrease compared to the postivie 
control (Figure 9-10).  Although these results indicate that yeast to hyphae shift should 
be reduced or inhibited completely, 95% of the yeast cells have turned hyphae by the 6 
h point (Table 2) for both strains.   
These results indicate that C. albicans is obtaining energy form other sources to 
ensure that the yeast to hyphae phenotype is not altered. For example, at least three 
mitochontrial respiratory pathways have been identified in this yeast (Deepu 2012) which 
could be sustaining the energy needs for the phenotypic shift. These pathways must 
must be evaluated to fully understand the potential of targeting respriation using for a 
potential anti-fungal agent. Nonetheless, this research is significant as it the first to  
monitor the classic OXPHOS enzymes throughout transition and when treated with a 
potenial anti-fungal agent using repiration as the target.  
5.    CONCLUSION: 
In this study we determined the ability of the phenolic acids, ferulic and gallic 
acid, to modulate the activity of the enzyme complexes (II, III, IV, V), the mitochondrial 
matrix marker enzyme citrate synthase, and the combined activity of complexes II and III 
involved in oxidative phosphorylation, of C. albicans (SC5314 and A72) during 
transitions from yeast to hyphae at each of the following time points: 0, 1, 3, and 6 hours.  
These results indicate that: 
 OXPHOS enzyme, CI, does not affect C. albicans respiration leading to the 
yeast-hyphae switch, but most likely continues to establish a potential across the 
inter-membrane and inner membrane throughout the transition period.  
 OXPHOS respiration of the two C. albicans strains (SC5314 and A72) differ 
despite similar morphologies over the course of the transition at 0, 1, 3, and 6 hr. 
55 
 
 
 For C. albicans strain A72 at the 6 hr period, all the enzymes are much lower 
which indicates that a high amount of energy is needed for the transition to its 
yeast form. 
 The enzyme activities of C. albicans SC5314 are much lower compared to A72 
which suggests it may not be as difficult to prevent the phenotypic switch in 
SC5314, as the energy may be conserved for producing virulence factors that 
occur later in transition.    
 Different treatment options most likely are warranted when OXPHOS is used as 
a potential target for inhibiting the yeast to hyphae transition, since in the two 
strains of C. albicans respiration is acting much differently. 
 Lower concentrations of isolated phenolic acids, ferulic and gallic acid, prevent 
hyphal growth by 25-50%. These concentrations also, inhibit the enzyme activity 
involved in oxidative phosphorylation of C. albicans (SC5314 and A72).   
 Gallic and ferulic acids reduced or inhibited the yeast to hyphae shift should be 
complete, 95% of the yeast cells have turned hyphae by the 6 hr for both 
species.  These results indicate that C. albicans is obtaining energy from other 
sources to ensure that the yeast to hyphae phenotype is not altered. 
 Gallic acid could lead to reprogramming respiration at the 3 hr transition point in 
contrast to what was typically the 1 hr point for the positive control on C. albicans 
(SC5314). This may partially protect against C. albicans virulence by lengthening 
the time switch and possibly other virulent factors.   
 C. albicans is obtaining energy from other sources to ensure that the yeast to 
hyphae phenotype is not altered when it is treated with ferulic acid. 
In future work, further tests are needed to establish the mechanism of inhibition 
of OXPHOS on C. albicans by ferulic and gallic acid, such as by studying enzyme 
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kinetics. Also, it is worth studying the effect of phenols in combination and whether they 
act synergistically to positively modulate the activity of the oxidative phosphorylation 
enzymes, which would be reflected in the hyphal phenotype. 
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